Clinical trialNCT02158533CompletedPhase 3Interventional

A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study

SponsorAlkermes, Inc.Enrollment385Major Depressive Disorder

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Sanjeev Pathak, MD
Alkermes, Inc.
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

49 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

Alkermes Investigational Site
Brisbane, Queensland, Australia
Alkermes Investigational Site
Towong, Queensland, Australia
Alkermes Investigational Site
Frankston, Victoria, Australia
Alkermes Investigational Site
Melbourne, Victoria, Australia

Canada

Alkermes Investigational Site
Penticton, British Columbia, Canada
Alkermes Investigational Site
Gatineau, Quebec, Canada
Alkermes Investigational Site
Québec, Canada

United States

Alkermes Investigational Site
Birmingham, Alabama, United States
Alkermes Investigational Site
Tucson, Arizona, United States
Alkermes Investigational Site
Carson, California, United States
Alkermes Investigational Site
National City, California, United States
Alkermes Investigational Site
Orange, California, United States
Alkermes Investigational Site
Sherman Oaks, California, United States
Alkermes Investigational Site
Torrance, California, United States
Alkermes Investigational Site
Upland, California, United States
Alkermes Investigational Site
Hartford, Connecticut, United States
Alkermes Investigational Site
Norwich, Connecticut, United States
Alkermes Investigational Site
Coral Springs, Florida, United States
Alkermes Investigational Site
Gainesville, Florida, United States
Alkermes Investigational Site
Lauderhill, Florida, United States
Alkermes Investigational Site
Orlando, Florida, United States
Alkermes, Investigational Site
Alpharetta, Georgia, United States
Alkermes Investigational Site
Decatur, Georgia, United States
Alkermes Investigational Site
Chicago, Illinois, United States
Alkermes Investigational Site
Joliet, Illinois, United States
Alkermes Investigational Site
Skokie, Illinois, United States
Alkermes Investigational Site
Newburgh, Indiana, United States
Alkermes Investigational Site
Valparaiso, Indiana, United States
Alkermes Investigational Site
Owensboro, Kentucky, United States
Alkermes Investigational Site
Baltimore, Maryland, United States
Alkermes Investigational Site
Baltimore, Maryland, United States
Alkermes Investigational Site
Berlin, New Jersey, United States
Alkermes Investigational Site
Brooklyn, New York, United States
Alkermes Investigational Site
Mount Kisco, New York, United States
Alkermes Investigational Site
New York, New York, United States
Alkermes Investigational Site
Staten Island, New York, United States
Alkermes Investigational Site
Canton, Ohio, United States
Alkermes Investigational Site
Dayton, Ohio, United States
Alkermes Investigational Site
Oklahoma City, Oklahoma, United States
Alkermes Investigational Site
Oklahoma City, Oklahoma, United States

9 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 May 2014
Primary completion: 31 Dec 2015
Completion: 31 Dec 2015
Last update posted: 14 Aug 2019
Registered enrollment: 385
Registry id: NCT02158533

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.